New Breast Cancer Drug Cuts Disease Return Risk by 53%

A groundbreaking cancer treatment just gained FDA approval to help thousands of women with early-stage breast cancer avoid recurrence.

ENHERTU can now be used both before and after surgery, potentially saving lives by stopping cancer from coming back.